Login to Your Account



The TRICs up Lung Cancer's Sleeve

With Unique MOA, HER4 Joins EGFR Family Cancer Targets

By Anette Breindl
Science Editor

Wednesday, February 6, 2013
Studying cancer cells that survive chemotherapy treatment, scientists from Roche AG subsidiary Genentech Inc. have implicated a member of the human epidermal growth factor receptor, or HER, family in such treatment resistance.In their experiments, senior author Erica Jackson and her team looked at mouse models of non-small-cell lung cancer.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription